GlaxoSmithKline (GB:GSK) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GSK plc has announced that key executives, including CEO Emma Walmsley and CFO Julie Brown, have acquired ordinary shares under the company’s Share Reward Plan. The transactions took place on November 11, 2024, at a price of £13.9893 per share on the London Stock Exchange. This move may signal confidence in the company’s growth prospects and could be of interest to investors tracking insider activities.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.